Taro Shareholder Value Creation and Strategic Overview

16 Net Sales Composition North America and Derm Focused Source: Taro 2023 Form 20-F By Product Type 3% 12% 6% 2%. 9% By Country 8% 5% 24% 63% 68% Dermatological & Topical Neuropsychiatric Allergy Cardiovascular Anti-inflammatory Other U.S.A. Canada Israel International TARO

View entire presentation